Outcomes of COVID-19 in Patients with Skin Cancer.
Citation: British Journal of Dermatology. 185(3):654-655, 2021 09.PMID: 33837520Institution: MedStar Washington Hospital CenterDepartment: Dermatology | Dermatology ResidencyForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *COVID-19 | *Skin Neoplasms | Humans | Risk Factors | SARS-CoV-2Year: 2021ISSN:- 0007-0963
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33837520 | Available | 33837520 |
The effect of skin cancer diagnosis on the risk of adverse outcomes from COVID-19 remains unknown. Few studies have shown cancer patients with COVID-19 have higher rates of mortality and hospitalizations compared to those without cancer, perhaps due to a combination of delayed diagnosis and pre-existing comorbidities from chemotherapy and radiation treatments.1. Copyright This article is protected by copyright. All rights reserved.
English